Amneal Pharmaceuticals, Inc 10-K for FY2025
Amneal Pharmaceuticals, Inc. (AMRX)
10-K
2026-02-27
For: 2025-12-31
View Original
Added on
April 06, 2026
About this 10-K
Amneal Pharmaceuticals, Inc filed this 10-K on February 27, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $3.02B
- up 8.0% from $2.79B a year earlier
- Net income
- $72.06M
- compared with a net loss of $116.89M a year earlier
- Diluted EPS
- $0.22
- compared with -$0.38 a year earlier